209 reports of this reaction
2.6% of all GUANFACINE HYDROCHLORIDE reports
#4 most reported adverse reaction
AGGRESSION is the #4 most commonly reported adverse reaction for GUANFACINE HYDROCHLORIDE, manufactured by Amneal Pharmaceuticals LLC. There are 209 FDA adverse event reports linking GUANFACINE HYDROCHLORIDE to AGGRESSION. This represents approximately 2.6% of all 8,032 adverse event reports for this drug.
Patients taking GUANFACINE HYDROCHLORIDE who experience aggression should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
AGGRESSION is a less commonly reported adverse event for GUANFACINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to aggression, the following adverse reactions have been reported for GUANFACINE HYDROCHLORIDE:
The following drugs have also been linked to aggression in FDA adverse event reports:
AGGRESSION has been reported as an adverse event in 209 FDA reports for GUANFACINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
AGGRESSION accounts for approximately 2.6% of all adverse event reports for GUANFACINE HYDROCHLORIDE, making it a notable side effect.
If you experience aggression while taking GUANFACINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.